Micki Hultquist

1.7k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

Micki Hultquist is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Micki Hultquist has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Micki Hultquist's work include Respiratory viral infections research (5 papers), Influenza Virus Research Studies (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Micki Hultquist is often cited by papers focused on Respiratory viral infections research (5 papers), Influenza Virus Research Studies (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Micki Hultquist collaborates with scholars based in United States, Spain and Canada. Micki Hultquist's co-authors include Edward M. Connor, Robert Walker, George Kemble, Timo Vesikari, Robert B. Belshe, Kathryn M. Edwards, Genevieve A. Losonsky, Brian Harris, Xavier Carbonell‐Estrany and Ron Dagan and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Micki Hultquist

14 papers receiving 1.2k citations

Hit Papers

Live Attenuated versus Inactivated Influenza Vaccine in I... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
    2007 611 citations Robert B. Belshe, Kathryn M. Edwards et al. New England Journal of Medicine profile →

Peers

Micki Hultquist
Odile Launay France
Thomas C. Shope United States
Josep Costa Spain
Greet J. Boland Netherlands
Sander van Assen Netherlands
Sylvie Ranger‐Rogez France
Paola Chionne Italy
Tamae Hamaki Japan
Maria K. Smatti Qatar
Francesco Mannelli Italy
Odile Launay France
Micki Hultquist
Citations per year, relative to Micki Hultquist Micki Hultquist (= 1×) peers Odile Launay

Countries citing papers authored by Micki Hultquist

Since Specialization
Citations

This map shows the geographic impact of Micki Hultquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micki Hultquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micki Hultquist more than expected).

Fields of papers citing papers by Micki Hultquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micki Hultquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micki Hultquist. The network helps show where Micki Hultquist may publish in the future.

Co-authorship network of co-authors of Micki Hultquist

This figure shows the co-authorship network connecting the top 25 collaborators of Micki Hultquist. A scholar is included among the top collaborators of Micki Hultquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micki Hultquist. Micki Hultquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bruce, Ian N, Richard Furie, Eric F. Morand, et al.. (2022). Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials. Annals of the Rheumatic Diseases. 81(7). 962–969. 26 indexed citations
2.
Kalunian, Kenneth, Richard Furie, Eric F. Morand, et al.. (2022). A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus. Arthritis & Rheumatology. 75(2). 253–265. 82 indexed citations
3.
Greth, Warren, Gabriel J. Robbie, Philip Z. Brohawn, Micki Hultquist, & Bing Yao. (2016). Targeting the Interferon Pathway with Sifalimumab for the Treatment of Systemic Lupus Erythematosus. Immunotherapy. 9(1). 57–70. 11 indexed citations
4.
Oh, Chad K., Richard Leigh, Kimmie McLaurin, et al.. (2013). A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respiratory Research. 14(1). 93–93. 101 indexed citations
5.
Oh, Chad K., Kimmie McLaurin, Keunpyo Kim, Micki Hultquist, & Néstor A. Molfino. (2012). A Phase 2b, Randomized Study To Evaluate The Clinical Activity And Safety Profile Of Subcutaneous MEDI-528, An Anti-IL-9 Monoclonal Antibody, In Adults With Uncontrolled Asthma. A2760–A2760. 2 indexed citations
6.
Langley, Richard G., Kim Papp, Robert Bissonnette, et al.. (2010). Safety profile of intravenous and subcutaneous siplizumab, an anti‐CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double‐blind, placebo‐controlled studies. International Journal of Dermatology. 49(7). 818–828. 22 indexed citations
7.
8.
Carbonell‐Estrany, Xavier, Eric A. F. Simões, Ron Dagan, et al.. (2009). Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. PEDIATRICS. 125(1). e35–e51. 181 indexed citations
9.
Lagos, Rosanna, John P. DeVincenzo, Alma Muñoz, et al.. (2009). SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN. The Pediatric Infectious Disease Journal. 28(9). 835–837. 44 indexed citations
10.
Bissonnette, Robert, Richard G. Langley, Kim Papp, et al.. (2009). Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab. Archives of Dermatological Research. 301(6). 429–442. 12 indexed citations
11.
12.
Belshe, Robert B., Kathryn M. Edwards, Timo Vesikari, et al.. (2007). Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children. New England Journal of Medicine. 356(7). 685–696. 611 indexed citations breakdown →
13.
Block, Stan L., Keith S. Reisinger, Micki Hultquist, & Robert Walker. (2007). Comparative Immunogenicities of Frozen and Refrigerated Formulations of Live Attenuated Influenza Vaccine in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 51(11). 4001–4008. 27 indexed citations
14.
Ouriel, Kenneth, et al.. (1999). Prourokinase versus Urokinase for Recanalization of Peripheral Occlusions, Safety and Efficacy: The PURPOSE Trial. Journal of Vascular and Interventional Radiology. 10(8). 1083–1091. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Odile Launay Breakdown of academic impact, for papers by Thomas C. Shope Breakdown of academic impact, for papers by Josep Costa Breakdown of academic impact, for papers by Greet J. Boland Breakdown of academic impact, for papers by Sander van Assen Breakdown of academic impact, for papers by Sylvie Ranger‐Rogez Breakdown of academic impact, for papers by Paola Chionne Breakdown of academic impact, for papers by Tamae Hamaki Breakdown of academic impact, for papers by Maria K. Smatti Breakdown of academic impact, for papers by Francesco Mannelli
Rankless by CCL
2026